Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 ,inter alia, to consider and approve The Audited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has informed BSE that its Board of Directors will meet on Monday, May 12, 2025, at 5:00 PM at its registered office in Ahmedabad. The main agenda item is to consider and approve the Audited Standalone and Consolidated Financial Statements and Results for the quarter and financial year ended March 31, 2025. The meeting also has a standard 'any other business with permission of chair' clause. The trading window for insiders has already been closed and will reopen 48 hours after the results are declared.
This is a routine regulatory filing and not a result announcement itself, so it has no immediate impact on the stock. Investors should watch for the actual audited FY25 numbers on or after May 12, which could move the stock depending on performance.